Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Belite Bio, Inc. Sponsored ADR stock logo
BLTE
Belite Bio
$71.56
-1.6%
$62.54
$43.70
$86.53
$2.32B-1.4945,947 shs53,213 shs
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
$17.83
+2.3%
$14.56
$8.02
$17.83
$8.66B1.666.01 million shs5.58 million shs
Regencell Bioscience Holdings Limited stock logo
RGC
Regencell Bioscience
$13.42
-0.1%
$18.70
$0.09
$83.60
N/A2.2572,658 shs337,656 shs
Roivant Sciences Ltd. stock logo
ROIV
Roivant Sciences
$11.96
+3.4%
$11.36
$8.73
$13.06
$7.87B1.154.49 million shs6.86 million shs
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Belite Bio, Inc. Sponsored ADR stock logo
BLTE
Belite Bio
+4.65%+9.68%+15.04%+18.07%+49.80%
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
+1.85%+22.33%+16.94%+35.25%+33.03%
Regencell Bioscience Holdings Limited stock logo
RGC
Regencell Bioscience
-0.59%-0.15%-8.88%+1,343,999,900.00%+1,343,999,900.00%
Roivant Sciences Ltd. stock logo
ROIV
Roivant Sciences
+3.58%-0.52%+1.85%+8.43%+3.49%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Belite Bio, Inc. Sponsored ADR stock logo
BLTE
Belite Bio
2.4228 of 5 stars
3.53.00.00.02.30.80.6
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
3.3556 of 5 stars
2.44.00.00.32.51.71.3
Regencell Bioscience Holdings Limited stock logo
RGC
Regencell Bioscience
0.1749 of 5 stars
0.02.00.00.02.70.00.0
Roivant Sciences Ltd. stock logo
ROIV
Roivant Sciences
2.0991 of 5 stars
3.61.00.00.01.63.30.0
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Belite Bio, Inc. Sponsored ADR stock logo
BLTE
Belite Bio
3.00
Buy$96.6735.08% Upside
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
2.88
Moderate Buy$17.33-2.79% Downside
Regencell Bioscience Holdings Limited stock logo
RGC
Regencell Bioscience
0.00
N/AN/AN/A
Roivant Sciences Ltd. stock logo
ROIV
Roivant Sciences
3.25
Buy$16.5037.97% Upside

Current Analyst Ratings Breakdown

Latest BLTE, ROIV, ELAN, and RGC Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/11/2025
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$12.00 ➝ $18.00
8/8/2025
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$18.00 ➝ $19.00
7/23/2025
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$17.00 ➝ $18.00
7/17/2025
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
Leerink Partnrs
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Strong-Buy
7/17/2025
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
Leerink Partners
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeMarket Perform ➝ Outperform$18.00
7/10/2025
Roivant Sciences Ltd. stock logo
ROIV
Roivant Sciences
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy$19.00
7/3/2025
Belite Bio, Inc. Sponsored ADR stock logo
BLTE
Belite Bio
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$100.00
7/2/2025
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$16.00 ➝ $17.00
6/26/2025
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeMarket Perform ➝ Outperform
6/18/2025
Roivant Sciences Ltd. stock logo
ROIV
Roivant Sciences
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$18.00
5/28/2025
Roivant Sciences Ltd. stock logo
ROIV
Roivant Sciences
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$18.00
(Data available from 8/13/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Belite Bio, Inc. Sponsored ADR stock logo
BLTE
Belite Bio
N/AN/AN/AN/A$4.71 per shareN/A
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
$4.44B2.00$2.31 per share7.73$13.64 per share1.31
Regencell Bioscience Holdings Limited stock logo
RGC
Regencell Bioscience
N/AN/AN/AN/A$0.02 per shareN/A
Roivant Sciences Ltd. stock logo
ROIV
Roivant Sciences
$29.05M279.86N/AN/A$7.08 per share1.69
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Belite Bio, Inc. Sponsored ADR stock logo
BLTE
Belite Bio
-$36.14M-$1.36N/AN/AN/AN/A-34.90%-33.56%N/A
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
$338M$0.8620.7320.033.239.68%7.04%3.45%N/A
Regencell Bioscience Holdings Limited stock logo
RGC
Regencell Bioscience
-$4.30MN/A0.00N/AN/AN/AN/AN/A
Roivant Sciences Ltd. stock logo
ROIV
Roivant Sciences
-$171.98M-$0.25N/AN/AN/A-2,111.79%-15.90%-14.95%N/A

Latest BLTE, ROIV, ELAN, and RGC Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/11/2025Q2 2025
Belite Bio, Inc. Sponsored ADR stock logo
BLTE
Belite Bio
-$0.47-$0.50-$0.03-$0.50N/AN/A
8/7/2025Q2 2025
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
$0.1989$0.26+$0.0611$0.02$1.19 billion$1.24 billion
5/29/2025Q4 2025
Roivant Sciences Ltd. stock logo
ROIV
Roivant Sciences
-$0.16-$0.31-$0.15-$0.29$62.17 million$7.57 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Belite Bio, Inc. Sponsored ADR stock logo
BLTE
Belite Bio
N/AN/AN/AN/AN/A
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
N/AN/AN/AN/AN/A
Regencell Bioscience Holdings Limited stock logo
RGC
Regencell Bioscience
N/AN/AN/AN/AN/A
Roivant Sciences Ltd. stock logo
ROIV
Roivant Sciences
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Belite Bio, Inc. Sponsored ADR stock logo
BLTE
Belite Bio
N/A
23.15
24.31
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
0.61
2.60
1.40
Regencell Bioscience Holdings Limited stock logo
RGC
Regencell Bioscience
N/AN/AN/A
Roivant Sciences Ltd. stock logo
ROIV
Roivant Sciences
N/A
40.54
33.47

Institutional Ownership

CompanyInstitutional Ownership
Belite Bio, Inc. Sponsored ADR stock logo
BLTE
Belite Bio
0.53%
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
97.48%
Regencell Bioscience Holdings Limited stock logo
RGC
Regencell Bioscience
0.13%
Roivant Sciences Ltd. stock logo
ROIV
Roivant Sciences
64.76%

Insider Ownership

CompanyInsider Ownership
Belite Bio, Inc. Sponsored ADR stock logo
BLTE
Belite Bio
13.29%
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
0.89%
Regencell Bioscience Holdings Limited stock logo
RGC
Regencell Bioscience
2.00%
Roivant Sciences Ltd. stock logo
ROIV
Roivant Sciences
10.80%
CompanyEmployeesShares OutstandingFree FloatOptionable
Belite Bio, Inc. Sponsored ADR stock logo
BLTE
Belite Bio
1031.84 million27.61 millionNot Optionable
Elanco Animal Health Incorporated stock logo
ELAN
Elanco Animal Health
9,000496.81 million492.39 millionOptionable
Regencell Bioscience Holdings Limited stock logo
RGC
Regencell Bioscience
10N/AN/AN/A
Roivant Sciences Ltd. stock logo
ROIV
Roivant Sciences
860679.81 million606.39 millionOptionable

Recent News About These Companies

Roivant Sciences (NASDAQ:ROIV) Shares Gap Down After Earnings Miss
Why Roivant Sciences Stock Was Slipping on Monday
An Overview of Exact Sciences's Earnings

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Belite Bio stock logo

Belite Bio NASDAQ:BLTE

$71.56 -1.17 (-1.61%)
Closing price 04:00 PM Eastern
Extended Trading
$71.56 0.00 (0.00%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Belite Bio, Inc, a clinical stage biopharmaceutical drug development company, engages in the research and development of novel therapeutics targeting retinal degenerative eye diseases with unmet medical needs in the United States. The company's lead product candidate is LBS-008 (Tinlarebant), an orally administered once-a-day tablet for maintaining the health and integrity of retinal tissues in autosomal recessive Stargardt disease and geographic atrophy patients. It is also developing LBS-009, an anti-retinol binding protein 4 oral therapy that is in the preclinical development phase targeting liver disease, including non-alcoholic fatty liver disease, nonalcoholic steatohepatitis, and type 2 diabetes. Belite Bio, Inc was founded in 2016 and is based in San Diego, California. Belite Bio, Inc is a subsidiary of Lin Bioscience International Ltd.

Elanco Animal Health stock logo

Elanco Animal Health NYSE:ELAN

$17.83 +0.40 (+2.29%)
Closing price 03:59 PM Eastern
Extended Trading
$17.70 -0.13 (-0.76%)
As of 07:14 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.

Regencell Bioscience stock logo

Regencell Bioscience NASDAQ:RGC

$13.42 -0.02 (-0.15%)
As of 04:00 PM Eastern

Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.

Roivant Sciences stock logo

Roivant Sciences NASDAQ:ROIV

$11.96 +0.39 (+3.36%)
Closing price 03:59 PM Eastern
Extended Trading
$12.00 +0.04 (+0.30%)
As of 07:48 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Roivant Sciences Ltd., a commercial-stage biopharmaceutical company, engages in the development and commercialization of medicines for inflammation and immunology areas. The company provides Vants, a model to develop and commercialize its medicines and technologies focusing on biopharmaceutical businesses, discovery-stage companies, and health technology startups. It develops VTAMA, a novel topical for the treatment of psoriasis and atopic dermatitis; batoclimab and IMVT-1402, the fully human monoclonal antibodies targeting the neonatal Fc receptor across various IgG-mediated autoimmune indications; and RVT-3101, an anti-TL1A antibody for ulcerative colitis and Crohn's disease. The company was founded in 2014 and is based in London, the United Kingdom.